Research / SIF / Fundamental state Inspectable configuration
State dimensions Filing 0000090168-22-000020 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
82.88% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.18% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-18.05% · OPTIONAL · NOT_ENOUGH_HISTORY
Share-count growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.shares_outstanding
0.84% · CORE · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-1.20% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
59.16% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
5.94% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-5.23% · CORE · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.59% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/9 normalized Level 3 Jun 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 6/8 normalized Level 3 Mar 31, 2023 6/8 normalized Level 3 Jun 30, 2023 6/8 normalized Level 3 Sep 30, 2023 6/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 5/6 normalized Level 3 Dec 31, 2025 6/6 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 107.58%
Current 82.88%
Delta -24.70% Capex Intensity Increased
Previous 2.42%
Current 4.18%
Delta 1.76% Cash Generation Decreased
Previous 6.44%
Current -18.05%
Delta -24.49% Dilution Increased
Previous 0.74%
Current 0.84%
Delta 0.10% Growth Increased
Previous -23.25%
Current -1.20%
Delta 22.05% Inventory Pressure Decreased
Previous 77.83%
Current 59.16%
Delta -18.66% Margin Increased
Previous 0.05%
Current 5.94%
Delta 5.89% Profitability Increased
Previous -18.97%
Current -5.23%
Delta 13.75% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.